Johnson  Johnson Acquires U.S. Biotech Firm Ollin Biosciences for Up to $3.325 Billion
Trendline

Johnson Johnson Acquires U.S. Biotech Firm Ollin Biosciences for Up to $3.325 Billion

What's Happening? Johnson & Johnson has announced an agreement to acquire U.S. biotechnology firm Ollin Biosciences. The deal includes an upfront payment of $2.2 billion, with potential milestone payments of up to $1.125 billion tied to regulatory and commercial achievements, bringing the total maxi
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.